Unilever PLC — 2020 Form 20-F Summary
Reporting period and business context: Annual report for the fiscal year ended December 31, 2020, prepared under IFRS as issued by the IASB. Unilever is a global consumer-goods company with Beauty & Personal Care, Foods & Refreshment, and Home Care divisions. The year was materially affected by COVID-19, lockdowns, and sharp shifts in consumer demand and shopping channels.
Key financial results
| Metric | 2020 | 2019 |
|---|---|---|
| Turnover | €50.7 billion | €52.0 billion |
| Underlying sales growth | 1.9% (volume 1.6%; price 0.3%) | 2.9% |
| Operating profit | €8.3 billion | €8.7 billion |
| Underlying operating profit | €9.4 billion, down 5.8% reported; up 0.7% at constant exchange rates | €9.9 billion |
| Operating margin | 16.4% | 16.8% |
| Underlying operating margin | 18.5% | 19.1% |
| Net profit | €6.1 billion | €6.0 billion |
| Diluted earnings per share | €2.12 | €2.14 |
| Cash flow from operating activities | €10.9 billion | €10.6 billion |
| Free cash flow | €7.7 billion | €6.1 billion |
| Net debt | €20.9 billion | €23.1 billion |
| Cash and cash equivalents | €5.5 billion | €4.2 billion |
| Dividends paid on ordinary capital | €4.3 billion | €4.2 billion |
Turnover fell 2.4%, mainly due to a 5.4% adverse currency impact; acquisitions net of disposals contributed positively. Underlying operating margin contracted 60 basis points. Management attributed pressure largely to COVID-related supply-chain costs and unfavorable sales mix. Free cash flow benefited from working-capital movements and rephased capital expenditure; it is a non-GAAP measure and does not deduct debt principal repayments.
Divisions and changes versus prior year
- Beauty & Personal Care: Turnover €21.1 billion; underlying sales growth 1.2%; underlying operating margin 21.7%, versus 22.7% in 2019. Hygiene and skin cleansing grew, while deodorants, hair care, skin care, and prestige beauty faced weaker demand or closures.
- Foods & Refreshment: Turnover €19.1 billion; underlying sales growth 1.3%; underlying operating margin 17.0%, versus 17.5%. In-home foods benefited from more cooking at home, while food solutions fell 30% as out-of-home channels closed.
- Home Care: Turnover €10.5 billion; underlying sales growth 4.5%; underlying operating margin 14.5%, versus 14.8%. Hygiene and cleaning demand supported growth.
- E-commerce sales rose 61% and represented 9% of total sales. More than 60% of the business was winning market share in the final quarter, according to management.
Balance sheet, liquidity, and financing
Total assets were €67.7 billion and total liabilities €50.0 billion at year-end. Financial liabilities were €27.3 billion, including €22.9 billion of bonds; cash and cash equivalents were €5.5 billion. Unilever reported undrawn committed bilateral credit facilities of $7.965 billion and said its financing arrangements were adequate for foreseeable working-capital needs. It reported a long-term credit rating of A+/A1 and aims to maintain at least A/A2 over the long term. Debt maturities and interest obligations are detailed in the filing; approximately €1.6 billion of bonds were due within one year.
Outlook, management commentary, risks, and unusual items
- Outlook: Management described trading conditions as likely to remain difficult while COVID-19 effects persisted. Its multi-year financial framework targets underlying sales growth of 3%–5%, profit growth ahead of sales growth on a comparable basis, sustained strong cash flow, annual savings of €2 billion, ROIC in the mid-to-high teens, and net debt around 2x underlying EBITDA. These are framework objectives, not a specific 2021 earnings forecast. Restructuring investment was expected to be about €1 billion in 2021–2022, lower thereafter.
- Strategy and portfolio: Unilever completed its legal unification under Unilever PLC on November 29, 2020, issuing 1.46 billion new PLC shares to former NV shareholders. It acquired the GSK health-food drinks portfolio, including Horlicks and Boost, as well as Liquid I.V. and SmartyPants Vitamins. Following a strategic review, it said it would separate its global tea business, with stated exceptions for India, Indonesia, and ready-to-drink tea joint ventures.
- Unusual items: Operating profit included €1.064 billion of non-underlying charges, mainly €916 million of restructuring costs. A further €87 million charge related to litigation matters involving competition-authority investigations. The Horlicks acquisition involved provisional valuations, including €3.3 billion of acquired intangible assets and €2.0 billion of goodwill for the main acquisition.
- Contingencies: Total disclosed contingent liabilities were €3.51 billion, including €2.86 billion of Brazil tax matters. The largest item was a €2.04 billion assessment linked to a 2001 corporate reorganisation; Unilever said it believed the likelihood of the authorities prevailing was low, but no outcome is assured. Separately, uncertain direct-tax provisions were €879 million.
- Other risks: The filing highlights consumer preference and competition, customer relationships, supply-chain disruption, commodity and currency volatility, product safety, cyber and IT resilience, climate change, plastic packaging, talent, political and economic instability, and tax, legal, and regulatory matters. COVID-19 increased the likelihood or potential impact of several risks.
- Sustainability and unusual disclosures: The company reported progress on its 2039 net-zero value-chain ambition and 2025 plastic goals, while acknowledging that it missed or fell short of several earlier sustainability targets, including consumer-use water and sustainable sourcing. The filing also reports Iran-related sales by a non-US subsidiary of about €10.7 million and net profits below €5.2 million attributable to sales to specified government-affiliated entities; the subsidiary had chosen to discontinue sales to three named entities.
KPMG issued an unqualified audit opinion and concluded that internal control over financial reporting was effective. Management’s control assessment excluded acquired businesses representing approximately 11% of total assets and 1% of turnover.
Most important facts for investors to verify
- Whether the improvement in free cash flow is repeatable, given its reliance on favorable working capital and rephased capital expenditure.
- How sales growth, market share, and margins recover as COVID-related disruption and channel mix effects change.
- Execution and costs of restructuring, the tea-business separation, acquisitions, and the new PLC-only structure.
- Progress toward the 3%–5% underlying sales growth framework and the stated leverage, savings, and ROIC objectives.
- Developments in the €2.04 billion Brazil tax contingency, other tax exposures, and competition-authority investigations.
- Debt refinancing and liquidity around near-term maturities, and the effect of currency movements on reported results and equity.
- Whether Horlicks acquisition valuations and associated tax assumptions remain supportable as purchase accounting is finalized.